1. Home
  2. BIT vs DNA Comparison

BIT vs DNA Comparison

Compare BIT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Multi-Sector Income Trust of Beneficial Interest

BIT

BlackRock Multi-Sector Income Trust of Beneficial Interest

HOLD

Current Price

$13.16

Market Cap

573.0M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.39

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIT
DNA
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
573.0M
562.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIT
DNA
Price
$13.16
$9.39
Analyst Decision
Strong Sell
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
92.4K
979.7K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
9.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$180,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.65
$5.00
52 Week High
$15.97
$17.58

Technical Indicators

Market Signals
Indicator
BIT
DNA
Relative Strength Index (RSI) 47.07 47.51
Support Level $13.10 $8.56
Resistance Level $13.29 $10.05
Average True Range (ATR) 0.08 0.55
MACD 0.01 0.27
Stochastic Oscillator 45.99 65.25

Price Performance

Historical Comparison
BIT
DNA

About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest

BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loan and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: